Mandate

Vinge advises Cantargia on share issues

November 10, 2017

Vinge advises Cantargia AB (publ) (Nasdaq First North) in connection with a combined directed issue and rights offering of SEK 232 million.

The Vinge team includes Erik Sjöman, Christian Lindhé, Kristoffer Franzkeit and Ludvig Frithiof.

Related

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024